Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Testori

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Cancer Discovery|May 15, 2016
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed PhenotypeDaniela Bossi, Angelo Cicalese, Gaetano I Dellino, et al.
The Lancet. Oncology|April 5, 2015
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trialAlexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Nutrients|July 2, 2021
Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled TrialHarriet Johansson, Giuseppe Spadola, Giulio Tosti, et al.
Carcinogenesis|October 13, 2019
Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 geneMarianna Avitabile, Mariangela Succoio, Alessandro Testori, et al.
Journal of the American Academy of Dermatology|June 9, 2009
Clinical genetic testing for familial melanoma in Italy: a cooperative studyWilliam Bruno, Paola Ghiorzo, Linda Battistuzzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findingsFiliberto Belli, Alessandro Testori, Licia Rivoltini, et al.
The New England Journal of Medicine|June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutationPaul B Chapman, Axel Hauschild, Caroline Robert, et al.
The New England Journal of Medicine|October 9, 2016
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant TherapyAlexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteriaAugustinus P T van der Ploeg, Alexander C J van Akkooi, Piotr Rutkowski, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Cancer Discovery|May 15, 2016
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed PhenotypeDaniela Bossi, Angelo Cicalese, Gaetano I Dellino, et al.
The Lancet. Oncology|April 5, 2015
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trialAlexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Nutrients|July 2, 2021
Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled TrialHarriet Johansson, Giuseppe Spadola, Giulio Tosti, et al.
Carcinogenesis|October 13, 2019
Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 geneMarianna Avitabile, Mariangela Succoio, Alessandro Testori, et al.
Journal of the American Academy of Dermatology|June 9, 2009
Clinical genetic testing for familial melanoma in Italy: a cooperative studyWilliam Bruno, Paola Ghiorzo, Linda Battistuzzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findingsFiliberto Belli, Alessandro Testori, Licia Rivoltini, et al.
The New England Journal of Medicine|June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutationPaul B Chapman, Axel Hauschild, Caroline Robert, et al.
The New England Journal of Medicine|October 9, 2016
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant TherapyAlexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteriaAugustinus P T van der Ploeg, Alexander C J van Akkooi, Piotr Rutkowski, et al.
Pageof 16